RT Journal Article
SR Electronic
T1 SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.19.21253620
DO 10.1101/2021.03.19.21253620
A1 Sully Márquez
A1 Belén Prado-Vivar
A1 Juan José Guadalupe
A1 Mónica Becerra-Wong
A1 Bernardo Gutierrez
A1 Clinical COVID-19 Ecuador Consortium
A1 Juan Carlos Fernández-Cadena
A1 Derly Andrade-Molina
A1 Gabriel Morey-Leon
A1 Miguel Moncayo
A1 Rommel Guevara
A1 Josefina Coloma
A1 Gabriel Trueba
A1 Michelle Grunauer
A1 Verónica Barragán
A1 Patricio Rojas-Silva
A1 Paúl Cárdenas
YR 2021
UL http://medrxiv.org/content/early/2021/03/24/2021.03.19.21253620.abstract
AB SARS-CoV-2, the etiological agent of COVID-19, was first described in Wuhan, China in December 2019 and has now spread globally. Ecuador was the second country in South America to confirm cases and Guayaquil was one of the first cities in the world to experience high mortality due to COVID-19. The aim of this study was to describe the lineages circulating throughout the country and to compare the mutations in local variants, to the reference strain. In this work we used the MinION platform (Oxford Nanopore Technologies) to sequence the whole SARS-CoV-2 genomes of 119 patients from all provinces of Ecuador, using the ARTIC network protocols. Our data from lineage assignment of the one hundred and nineteen whole genomes revealed twenty different lineages. All genomes presented differences in the S gene compared to the Wuhan reference strain, being the D614G amino acid replacement the most common change. The B.1.1.119 lineage was the most frequent and was found in several locations in the Coast and Andean region. Three sequences were assigned to the new B.1.1.7 lineage. Our work is an important contribution to the understanding of the epidemiology of SARS-CoV-2 in Ecuador and South America.HighlightsAll 119 genomes showed mutations compared to the reference strain, which could be important to understand the virulence, severity and transmissibility of the virus.Until January 17, three sequences were assigned to the new B.1.1.7 lineage.Our findings suggest that there were at least twenty independent introductions of SARS-CoV-2 to Ecuador.Article Summary Line We report 119 sequences of SARS-CoV-2 across all Ecuadorian provinces, 20 different lineages were found until January 17th, including B.1.1.7.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe current project has been funded by USFQ through its Emergency grants, and CADDE through donations of reagents.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for all samples was given by CEISH-USFQ (Comite de Etica de Investigacion en Seres Humanos-USFQ): IE-JP067-2020-CEISH-USFQ. Additionally, by the Ministerio de Salud Publica Comite Expedito (021-2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are freely available on GISAID.org.